Status:
RECRUITING
HNC: Human Neural Circuits Electrophysiology During Cognition
Lead Sponsor:
Stanford University
Conditions:
Psychiatric Disorder
Eligibility:
All Genders
18+ years
Phase:
PHASE1
Brief Summary
The purpose of this study is to understand how ketamine brings about dissociative symptoms.
Detailed Description
The goal of this proposed research is to record the effects of ketamine on brain activity to understand the changes that occur during antidepressant therapy and the side effect of dissociation. This r...
Eligibility Criteria
Inclusion
- Patient in clinical neuro inpatient units at Stanford Medical Center
- Age \>18 years old
- Female participants are expected to use an effective method of birth control throughout the study which includes: hormonal methods (birth control pills, patches, injections, vaginal ring or implants), barrier methods (condom or diaphragm) used with spermicide, intrauterine device (IUD), or abstinence (no sex)
Exclusion
- Lifetime psychotic disorder
- Pregnant or nursing females
- Prior adverse ketamine response
- Use of ketamine in past 7 days
Key Trial Info
Start Date :
October 5 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 1 2030
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT05962424
Start Date
October 5 2023
End Date
September 1 2030
Last Update
August 26 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Stanford University
Palo Alto, California, United States, 94306